Life Science

A new study suggests that a key group of transcription factors are 'druggable,' including several that could be targeted to treat cancer, metabolic disease, or autoimmune conditions.
| 2 min read

A new study suggests that a key group of transcription factors are 'druggable,' including several that could be targeted to treat cancer, metabolic disease, or autoimmune conditions.